KR20150064724A - A Food composition for Teriyaki sauce comprising knotgrass extract - Google Patents
A Food composition for Teriyaki sauce comprising knotgrass extract Download PDFInfo
- Publication number
- KR20150064724A KR20150064724A KR1020150072742A KR20150072742A KR20150064724A KR 20150064724 A KR20150064724 A KR 20150064724A KR 1020150072742 A KR1020150072742 A KR 1020150072742A KR 20150072742 A KR20150072742 A KR 20150072742A KR 20150064724 A KR20150064724 A KR 20150064724A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- knotgrass
- teriyaki sauce
- sauce
- teriyaki
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 31
- 235000015067 sauces Nutrition 0.000 title abstract description 35
- 239000000203 mixture Substances 0.000 title abstract description 13
- 235000013305 food Nutrition 0.000 title abstract description 12
- 235000006386 Polygonum aviculare Nutrition 0.000 title abstract description 8
- 241000173219 Paspalum distichum Species 0.000 title abstract 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000004480 active ingredient Substances 0.000 claims abstract description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 13
- 230000002401 inhibitory effect Effects 0.000 abstract description 11
- 235000019640 taste Nutrition 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 239000004367 Lipase Substances 0.000 abstract description 3
- 102000004882 Lipase Human genes 0.000 abstract description 3
- 108090001060 Lipase Proteins 0.000 abstract description 3
- 235000019421 lipase Nutrition 0.000 abstract description 3
- 238000001914 filtration Methods 0.000 abstract description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 230000002292 Radical scavenging effect Effects 0.000 description 13
- 235000019439 ethyl acetate Nutrition 0.000 description 11
- 235000013555 soy sauce Nutrition 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 102000019280 Pancreatic lipases Human genes 0.000 description 8
- 108050006759 Pancreatic lipases Proteins 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 229940116369 pancreatic lipase Drugs 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 235000005881 Calendula officinalis Nutrition 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 208000008589 Obesity Diseases 0.000 description 7
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 235000020824 obesity Nutrition 0.000 description 7
- 150000002989 phenols Chemical class 0.000 description 7
- 240000001432 Calendula officinalis Species 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 230000001953 sensory effect Effects 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 244000291564 Allium cepa Species 0.000 description 4
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 4
- 206010013911 Dysgeusia Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- -1 butylated hydroxy anisol Chemical compound 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 4
- 229960001243 orlistat Drugs 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 240000004246 Agave americana Species 0.000 description 3
- 241001672694 Citrus reticulata Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 230000002366 lipolytic effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229930013915 (+)-catechin Natural products 0.000 description 2
- 235000007219 (+)-catechin Nutrition 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 239000008681 Phellinus linteus extract Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 244000292697 Polygonum aviculare Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000002038 ethyl acetate fraction Substances 0.000 description 2
- 235000013410 fast food Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000019643 salty taste Nutrition 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 240000001810 Angelica gigas Species 0.000 description 1
- 235000018865 Angelica gigas Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 244000058871 Echinochloa crus-galli Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000208368 Euonymus alatus Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 208000015580 Increased body weight Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000592238 Juniperus communis Species 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- 235000013418 Myrtus communis Nutrition 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- 235000011999 Panicum crusgalli Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 240000002924 Platycladus orientalis Species 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 244000088401 Pyrus pyrifolia Species 0.000 description 1
- 235000011400 Pyrus pyrifolia Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 235000002912 Salvia officinalis Nutrition 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 241000736851 Tagetes Species 0.000 description 1
- 235000012308 Tagetes Nutrition 0.000 description 1
- 240000000785 Tagetes erecta Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000001727 Tropicoporus linteus Species 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000883 anti-obesity agent Substances 0.000 description 1
- 229940125710 antiobesity agent Drugs 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002034 butanolic fraction Substances 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 239000002036 chloroform fraction Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229940029991 coriander extract Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 229940040461 lipase Drugs 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- CMFNMSMUKZHDEY-UHFFFAOYSA-N peroxynitrous acid Chemical compound OON=O CMFNMSMUKZHDEY-UHFFFAOYSA-N 0.000 description 1
- 229930189407 platycodin Natural products 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000004974 shell Anatomy 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A23L1/30—
-
- A23L1/3002—
-
- A23L1/39—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Seasonings (AREA)
Abstract
Description
본 발명은 데리야끼소스용 식품조성물에 관한 것으로서, 더욱 상세하게는 마디풀추출물을 유효성분으로 함유함으로써 지방분해효소(pancreatic lipase)를 효과적으로 억제하여 중성지방의 흡수를 방지하는 목적의 데리야끼소스용 식품조성물에 관한 것이다.The present invention relates to a food composition for teriyaki sauce, and more particularly, to a food composition for teriyaki sauce for the purpose of effectively inhibiting the lipase (pancreatic lipase) and preventing the absorption of triglyceride .
최근 산화적 스트레스와 관련된 각종 퇴행성 질환 및 생활습관성 질병이 사회적 문제가 되고 있으며 그 원인이 활성산소에 기인된 것으로 알려져 있다. 활성산소 종들은 superoxide, nitric oxide, nitrogen dioxide, hydroxyl, peroxynitrite 등이 있으며 인간의 대사과정 중에 끊임없이 발생되어 노화 및 관련질병의 주요인자로 작용하고 있다. 현재 널리 사용되고 있는 항산화제로서는 butylated hydroxy anisol(BHA) 및 butylated hydroxy toluene(BHT)등의 합성 항산화제이며, 이들을 50mg/kg/day 이상의 고용량으로 장기간 복용시 지질대사의 불균형과 암을 유발시킬 수 있기 때문에 사용의 제한을 권고하고 있는 실정이다. 이러한 합성 항산화제를 대체할 수 있는 우수한 소재의 개발이 요구되고 있는 실정이며, 최근에는 각종 천연소재 등에서 안전하고 항산화효과가 뛰어난 천연 항산화제를 개발하기 위한 많은 연구가 이루어지고 있다.
Recently, various degenerative diseases and lifestyle diseases related to oxidative stress have become a social problem and it is known that the cause is caused by active oxygen. The active oxygen species are superoxide, nitric oxide, nitrogen dioxide, hydroxyl, and peroxynitrite, which are constantly generated during human metabolism and act as a major factor in aging and related diseases. Currently, widely used antioxidants are synthetic antioxidants such as butylated hydroxy anisol (BHA) and butylated hydroxy toluene (BHT), which can induce an imbalance of the lipid metabolism and cancer when administered at a high dose of 50 mg / kg / Therefore, it is recommended to limit the use. In recent years, many studies have been conducted to develop a natural antioxidant which is safe and has excellent antioxidative effect in various natural materials.
최근 소득수준의 향상 및 산업의 발달로 인하여 식생활, 식습관 등 라이프스타일이 빠르게 서구화됨에 따라 만성질환이나 성인병환자가 급격히 증가하고 있는 실정이며 그 원인 중의 하나가 비만으로 알려져 있다. 비만은 섭취에너지와 소비에너지의 불균형에 의한 에너지대사이상으로서, 결과적으로 지방세포에 중성지방이 과도하게 축적된 상태로 정의된다. 비만의 가장 큰 원인은 고에너지나 고지방을 함유한 음식의 섭취 및 운동부족으로 인한 체중의 증가나 체지방 축적이지만 최근에는 신경내분비 계통의 이상, 약물, 유전적 요인 및 생화학적 이상반응에 의해서도 유발되는 것으로 보고되었다. 비만은 단순히 외형상의 문제 뿐만 아니라 체중증가와 더불어 고혈압, 제2형 당뇨병, 고혈압, 심장질환, 뇌졸중, 관절염, 동맥경화, 암 등의 질병과 밀접한 연관성이 알려져 있어 비만의 예방 및 치료와 관련된 소재개발의 필요성이 강조되는 실정이다.
Recently, as the lifestyle such as diet and eating habits has been rapidly westernized due to the improvement of income level and industrial development, chronic diseases and adult diseases are rapidly increasing. One of the causes is known as obesity. Obesity is an energy metabolic disorder caused by an imbalance between energy intake and energy consumption, and is consequently defined as an accumulation of excess fat in fat cells. The most common cause of obesity is increased body weight or body fat accumulation due to ingestion of high energy or high fat foods and lack of exercise, but recently it has also been caused by neuroendocrine abnormalities, drugs, genetic factors and biochemical abnormalities . Obesity is not only a matter of appearance but also a weight increase and it is known that it is closely related with diseases such as hypertension, type 2 diabetes, hypertension, heart disease, stroke, arthritis, arteriosclerosis and cancer. The need for the
최근에는 비만치료를 위해 식욕억제제, 열생산촉진제, 지방흡수억제제 등의 개발이 진행되고 있으며 대표적인 비만치료제로서 Orlistat(상품명:제니칼)은 중성지방(Triglyceride)을 분해하는 췌장의 지방분해효소인 pancreatic lipase에 비가역적인 결합을 하여 불활성화 시킴으로써 중성지방 및 콜레스테롤의 흡수를 감소시킴과 동시에 배설시키는 기작으로 항비만작용을 한다. 그러나 이와 같은 효능에도 불구하고 Orlistat은 복부고통, 설사, 지용성비타민 흡수억제 등의 부작용이 있는 것으로 알려져 있다. 따라서 최근에는 천연 항비만소재 개발을 위한 연구가 활발하게 진행되고 있으며, 길경(Platycodin grandiflorum), 세이지(Salvia officinalis), 우롱차로부터 지방분해효소를 억제하는 활성성분이 보고되었다. 최근에 비만관련의 천연선도 후보물질을 개발하기 위해 pancreatic lipase 저해효능을 가지는 천연 저해제로서 회잎나무(Euonymus alatus), 주니퍼베리(Juniperus communis), 측백나무(Thuja orientalis), 붓순나무(Illicum religiosum), 돌배나무(Pyrus pyrifolia) 추출물 등이 IC50=45 mg/mL이하의 강한 활성을 나타냄이 보고되었으며, 무환자나무로부터 분리된 사포닌, 사과의 procyanidin류 및 인삼 ginsenoside류에서도 강한 pancreatic lipase 저해능이 확인되었다. 마디풀의 EtOAc 가용부의 경우 12.5 mg/mL의 저농도에서 시판된 항비만 치료제 orlistat은 62.0±1.6%의 상당히 우수한 효능을 나타내었으며 농도의존적인 특성을 보였다.
In recent years, the development of appetite suppressants, heat stimulants, and fat absorption inhibitors has been underway for the treatment of obesity. Orlistat (brand name: Generic), a representative treatment for obesity, is a pancreatic lipase that degrades triglycerides And inactivates and inactivates irreversible binding to triglyceride and cholesterol. However, despite these benefits, Orlistat is known to have side effects such as abdominal pain, diarrhea, and inhibition of fat-soluble vitamin absorption. Recently, studies for the development of natural anti-obesity materials have been actively conducted, and active ingredients inhibiting lipolytic enzymes from Platycodin grandiflorum, Salvia officinalis and oolong tea have been reported. Recently, a natural inhibitor of pancreatic lipase inhibitory activity for the development of obesity-related natural-line candidates has been reported, including Euonymus alatus, Juniperus communis, Thuja orientalis, Illicum religiosum, Pyrus pyrifolia extract showed strong activity of IC 50 = 45 mg / mL or less. Saponin, apple procyanidin, and ginsenosides were also found to be highly potent inhibitors of pancreatic lipase. For the EtOAc soluble fraction of Angelica gigas Nakai, the commercially available anti-obesity agent orlistat showed a remarkable effect of 62.0 ± 1.6% at a low concentration of 12.5 mg / mL and showed a concentration-dependent property.
마디풀은 여귀과(Polygonaceae)에 속하는 한해살이풀로서 줄기는 둥근 기둥모양에 가지가 있으며 여름철 개화전에 지상부를 채취하여 건조한 것을 약용으로 사용하며, 어린 잎은 식용으로도 사용한다. 또, 마디풀의 전초를 건조하여 황달, 복통, 구충제, 혈뇨증, 설사, 이질, 류마티스, 고혈압 및 이뇨제로 이용하고 있다. 마디풀에 함유된 성분으로는 flavonoid, naphthoquinone, terpenoid, tannin 등이 보고되었고 혈소판응고 억제활성, 항염증활성 등이 알려져 있다.
It is an annual plant belonging to the family Polygonaceae. Its stem is rounded and has branches. It is used as a medicinal plant for drying in the summer before flowering, and young leaves are also used for food. It is also used as a jaundice, abdominal pain, insect repellent, hematuria, diarrhea, dysentery, rheumatism, hypertension and diuretic. Flavonoids, naphthoquinones, terpenoids, and tannins have been reported to be contained in the coriander. Platelet aggregation inhibitory activity and anti - inflammatory activity are known.
한편, 고도의 산업화로 인해 국민의 생활수준이 높아져 식생활에 대한 가치관이 변화되었고 식품의 소비패턴이 편의성과 시간절약형으로 급격히 바뀌었다. 이러한 변화는 가정에서도 조리시간을 줄이고 간편하게 구입할 수 있는 편의식품 및 소스류의 구입증가로 이어져 편의식품 및 소스류의 시장규모가 급격히 커지고 있음이 보고되었다. 특히 데리야끼소스는 생선의 뼈, 껍질, 머리, 결체조직과 향신채, 향신료를 첨가하고 장시간 끓임으로써 걸쭉한 농도와 단맛, 짠맛을 지닌 간장소스의 일종으로서 일본에서 유래되었으나 세계적으로도 널리 사용되고 있다. 생선의 살을 발라내고 남은 뼈나 껍질을 이용하여 만들기 때문에 식재료 중 버리는 부분까지 활용하고 껍질이나 뼈에 들어있는 영양성분을 활용하기 때문에 환경친화적인 소스로서 환경오염예방, 자원재활용 및 고부가가치를 창출할 수 있고, 특히 간장을 양념으로 많이 사용하고 있는 우리나라에서는 다양한 재료를 이용한 데리야끼소스의 제조와 활용이 가능하리라 생각된다.
On the other hand, due to the high level of industrialization, the standard of living of the people has increased and the value of food has changed, and the consumption pattern of food has changed drastically due to convenience and time saving. These changes have been reported to increase the market for convenience foods and sauces, leading to increased purchases of convenience foods and sauces that can be easily purchased at home, reducing cooking time at home. Teriyaki sauce is a type of soy sauce with a thick concentration, sweetness and salty taste by adding fish bones, shells, hair, connective tissues, spices and spices and boiling for a long time, but it is widely used in the world. Because it makes use of the remaining bone and shells, it utilizes the nutrients contained in the bark and bones and utilizes the abandoned parts of the ingredients. Therefore, it is environmentally friendly to prevent environmental pollution, recycle resources, and create high added value. In Korea, where soy sauce is widely used as sauce, it is thought that it is possible to manufacture and utilize teriyaki sauce using various materials.
현재까지 진행된 데리야끼소스에 대한 연구로는 간장에 관한 연구(Park WB,2001), 제조조건에 관한 연구(Park ML등,2007), 데리야끼소스의 제품응용성(Park HN등,2006), 주재료에 따른 데리야끼소스의 품질특성(Song CR & Choi SK,2009)등이 진행되었는데 제조시 다른 재료와 양념에 비해 상대적으로 많이 첨가되는 간장 및 설탕의 양, 가열시간에 대한 기준도 각기 달랐다. 그 후, 데리야끼소스의 가열시간에 관한 연구(Song CR, 2009), 반응표면분석을 통한 간장, 설탕, 가열시간의 최적화(Kim HY등, 2011)등이 진행되어 데리야끼소스에 대한 연구가 점차 증가함을 알 수 있었다.
Studies on the teriyaki sauce that has been carried out to date include studies on soy sauce (Park WB, 2001), studies on manufacturing conditions (Park ML et al., 2007), product application of teriyaki sauce (Park HN et al., 2006) (Song CR & Choi SK, 2009). However, the amount of soy sauce and sugar added and the heating time were different in comparison with other materials and seasonings. Thereafter, research on heating time of teriyaki sauce (Song CR, 2009), optimization of soy sauce, sugar and heating time through reaction surface analysis (Kim HY et al., 2011) .
한편, 마디풀에 관련된 국내특허로서 공개특허 제10-2005-0051320호가 공지되어 있는 바, 이에는 마디풀이 포함된 군에서 선택된 추출물을 혼합하여 제조한 숙취방지 및 제거용 조성물이 개시된 바 있다. 또, 국내등록특허 제10-0344325호에는 마디풀이 포함된 군에서 선택된 생약제를 혼합하여 변비증상 개선효과가 우수한 차 및 이의 제조방법이 개시된 바 있다. 마디풀에는 플라보노이드류 등의 화합물이 다수 존재하는 것이 알려져 있으나 항비만 후보물질에 관한 연구는 전무하였다. Meanwhile, Korean Patent Laid-Open No. 10-2005-0051320 is known as a domestic patent related to mandarin mushroom, which discloses a composition for preventing and removing hangover which is prepared by mixing extracts selected from the group comprising mandarin mushrooms. In addition, Korean Patent No. 10-0344325 discloses a tea having excellent effects for improving constipation symptoms by mixing a herbal medicine selected from the group comprising marigolds and a method for producing the same. It is known that there are many compounds such as flavonoids, but there have been no studies on antiobesity candidate substances.
따라서 본 발명의 목적은 천연소재로서 관능효과가 우수한 데리야끼소스용 조성물을 제공하는 것이다.Accordingly, an object of the present invention is to provide a composition for a teriyaki sauce having excellent sensory effect as a natural material.
본 발명의 또 다른 목적은 상기 데리야끼소스용 조성물을 함유하는 식품을 제공하는 데 있다.Yet another object of the present invention is to provide a food containing the composition for teriyaki sauce.
본 발명의 상기 목적은 마디풀을 에탄올로 추출한 후, 추출된 추출액을 여과하고 감압 농축하여 얻은 마디풀 추출물을 클로로포름(CHCl3), 에틸 아세테이트 (EtOAc), 부탄올(n-BuOH) 및 물(H2O) 순으로 계통분리하는 단계와; 각 분획물을 대상으로 라디칼 소거능 및 지방분해효소 저해능을 평가하는 단계와; 마디풀 추출물을 함유한 데리야끼 소스를 제조하는 단계와; 데리야끼소스의 수분, 점도 및 관능평가를 수행하는 단계를 통해 달성하였다.After extracting the above object of the present invention knotgrass with ethanol and filtering the extract the chloroform extract was knotgrass extract obtained was concentrated under reduced pressure (CHCl 3), ethyl acetate (EtOAc), butanol (n -BuOH) and water (H 2 O ) Systematic separation in order; Evaluating the radical scavenging ability and lipolytic enzyme inhibition ability of each fraction; Preparing a teriyaki sauce containing Marigold extract; And performing moisture, viscosity and sensory evaluation of the teriyaki sauce.
본 발명에 따른 마디풀 추출물 및 상기 마디풀 추출물의 에틸 아세테이트층 분획물, 부탄올층 분획물은 지방분해효소 활성을 억제하고 장 내 지방의 흡수를 억제하는 효과가 있다.The ethyl acetate fraction and the butanol fraction fraction of Maricelifera extract and Maricel extract according to the present invention have the effect of inhibiting lipase activity and inhibiting intestinal fat absorption.
도 1은 마디풀추출액 제조공정을 나타낸 도이다.FIG. 1 is a view showing a process for producing an extract of Marigold extract.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.
Hereinafter, the present invention will be described in more detail with reference to Examples. These embodiments are only for illustrating the present invention, and the scope of the present invention is not construed as being limited by these embodiments.
실시예 1: 마디풀 추출물의 제조 및 분획Example 1: Preparation and fractionation of marigold extract
본 발명에서 공시재료로 사용한 마디풀은 2008년 4월에 대구시 소재 흥생약업사에서 구입하여 세척하고 잘게 세절한 다음 사용하였으며, 표본시료는 대구한의대학교의 한약재약리학과 천연물화학실험실에 보관하고 있다.
In the present invention, it was purchased in April, 2008 from Heungsang Pharmaceutical Co., Ltd. in Daegu city, and washed and finely divided. The sample was stored in the herbal medicine pharmacology laboratory and the natural material chemical laboratory of Daegu Haany University.
마디풀 1kg을 45℃에서 10시간 동안 열풍건조한 후 분쇄기로 잘게 마쇄한 다음 80% 에탄올(EtOH) 3L로 3일 동안 3회 반복추출하여 얻은 용액을 여과한 후 감압농축하여 결과물(82g)을 얻었다.The resulting solution was filtered and concentrated under reduced pressure to obtain 82 g of a solution. The resulting solution was filtered, washed with water, and dried under reduced pressure.
농축 결과물 82g에 대하여 10% 에탄올 3L로 현탁하여 저극성용매인 클로로포름(CHCl3)으로 먼저 추출한 후 수층을 다시 에틸 EtOAc, n-butyl alcohol(n-BuOH)을 이용하여 각각 순차적으로 3회 분획하여 추출하였다. The resultant concentrate was suspended in 3 L of 10% ethanol and extracted first with chloroform (CHCl 3 ) as a low-polarity solvent. The water layer was fractionated three times in succession using ethyl EtOAc and n-butyl alcohol (n-BuOH) And extracted.
각 용매추출 분획을 감압농축하여 건조시킨 후 CHCl3 가용분획(7.7g), EtOAc 가용분획(6.5g), n-BuOH 가용분획(33.5g), H2O 가용분획(33.7g)을 각각 얻었다.
The solvent-extracted fractions were concentrated under reduced pressure and then dried to obtain a CHCl 3 soluble fraction (7.7 g), an EtOAc soluble fraction (6.5 g), an n-BuOH soluble fraction (33.5 g) and an H 2 O soluble fraction .
실시예 2: 총 페놀성 화합물 함량평가Example 2: Evaluation of total phenolic compound content
총 페놀성 화합물의 함량은 Folin-Denis방법에 따라 측정하였으며, 추출물 혹은 분획물을 1.0 mg/ml 농도로 조제한 후 75 mL의 증류수가 함유된 100 mL의 메스 플라스크에 1 mL 넣고 잘 혼합하여 Folin-Denis 시액 5 mL와 탄산나트륨 포화용액 10 mL를 차례로 넣은 다음 증류수로 100 ml용량으로 채운다. 그 다음 잘 혼합하여 실온에서 30분 동안 방치한 후 UV/VIS 분광광도계로 725 nm에서 흡광도를 측정하였고 표준물질은 gallic acid를 이용하여 표준곡선을 작성한 후 양을 환산하였다.
The total phenolic compound content was measured by Folin-Denis method. After preparing the extract or fraction at a concentration of 1.0 mg / ml, 1 mL was added to a 100 mL volumetric flask containing 75 mL of distilled water. Add 5 mL of the solution and 10 mL of the saturated solution of sodium carbonate in that order, and fill with 100 mL of distilled water. Then, the mixture was well mixed and allowed to stand at room temperature for 30 minutes. Absorbance was measured at 725 nm using a UV / VIS spectrophotometer. The standard curve was prepared using gallic acid and then converted to a standard curve.
마디풀 추출물 및 각 분획물에 함유된 총 페놀성 화합물의 함량을 [표 1]에 나타내었다. EtOAc 분획물이 1 g당 95.5±2.1 mg의 페놀성 화합물을 함유하는 것으로 나타났고 n-BuOH 분획물이 90.2±1.3 mg, CHCl3 분획물이 82.0±2.3 mg의 페놀성 화합물의 함량이 확인되었다. 또한 H2O 층에서는 1 g당 40.8±2.3 mg의 상대적으로 낮은 페놀함유량을 나타내는 것으로 분석되었다.The contents of total phenolic compounds contained in the extracts and the fractions were shown in Table 1. The EtOAc fraction was found to contain 95.5 ± 2.1 mg of phenolic compound per gram and the content of phenolic compounds of 90.2 ± 1.3 mg of n-BuOH and 82.0 ± 2.3 mg of CHCl 3 fraction was confirmed. It was also analyzed that the H 2 O layer exhibited a relatively low phenol content of 40.8 ± 2.3 mg per gram.
실시예 3: DPPH 라디칼소거능 측정Example 3: Measurement of DPPH radical scavenging activity
전자공여능은 Blois 방법에 따라 측정하였다. 각 시료용액 2 mL에 0.2 mM의 희석한 1,1-diphenyl-2-picrylhydrazyl(DPPH) 용액 1 mL를 넣고 교반한 후 30분 동안 방치한 다음 517 nm에서 흡광도를 측정하였다. 전자공여능은 시료용액의 첨가군과 무첨가군의 흡광도 차이를 백분율로 나타내었다.The electron donating ability was measured according to the Blois method. 1 mL of diluted 1, 1-diphenyl-2-picrylhydrazyl (DPPH) solution of 0.2 mM was added to 2 mL of each sample solution, and the mixture was left to stand for 30 minutes and absorbance was measured at 517 nm. The electron donating ability was expressed as a percentage of absorbance difference between the addition group and the no addition group of the sample solution.
DPPH는 생체 내에 존재하는 라디칼은 아니지만 그 자체가 홀수전자를 갖고 있어서 517 nm에서 강한 흡광도를 나타낸다. 따라서 항산화능이 있는 물질과 반응하게 되면 안정한 형태로 돌아가면서 흡광도 값이 감소하는 것이다.DPPH is not a radical present in vivo, but has an odd number of electrons itself, indicating a strong absorbance at 517 nm. Therefore, when reacting with a substance having antioxidant ability, the absorbance value decreases while returning to a stable form.
[표 2]에 나타낸 것처럼 마디풀 80% 에탄올 추출물 및 각 유기용매 분획에 대해서 라디칼소거능을 평가한 결과 200 mg/mL의 농도에서 에탄올 추출물이 59.6±2.7%의 라디칼소거능을 나타내었고, 특히 EtOAc 가용부의 100 mg/mL의 농도에서 58.1±2.3%의 우수한 라디칼소거능을 나타내었다. 이는 양성 대조군으로서 녹차 등의 항산화성분으로 잘 알려져 있는 (+)-catechin과 같은 농도에서 비교한 결과이다. n-BuOH 가용부의 100 mg/mL의 농도에서 38.7±1.6%, 62.5 mg/mL의 농도에서 25.0±1.8%의 라디칼소거능을 나타내었고, CHCl3 가용부 및 HO 층에서 비교적 약한 라디칼소거능을 나타내었다.As shown in Table 2, the radical scavenging activity of the ethanol extract of mandarin myrtle 80% ethanol and each organic solvent fraction was 59.6 ± 2.7% at the concentration of 200 mg / mL. Especially, the radical scavenging ability of EtOAc soluble fraction At the concentration of 100 mg / mL, it showed excellent radical scavenging ability of 58.1 ± 2.3%. This is the result of comparing the concentration of (+) - catechin which is well known as an antioxidant component such as green tea as a positive control. showed a radical scavenging activity of 38.7 ± 1.6% at a concentration of 100 mg / mL of the soluble portion of n-BuOH and 25.0 ± 1.8% at a concentration of 62.5 mg / mL and exhibited a relatively weak radical scavenging ability in the CHCl 3 soluble portion and the HO layer .
DPPH 라디칼소거능과 총 페놀성화합물의 함량사이에는 밀접한 상관관계가 있다는 보고(Wang 등, J Agric Food Chem, 2003)에 근거하여 마디풀의 항산화활성과 페놀성화합물의 연관성을 평가한 결과, DPPH 라디칼소거능은 페놀성화합물의 함량이 상대적으로 높은 EtOAc 층에서 가장 높은 것이 확인되었고, 이는 마디풀의 항산화활성이 마디풀추출물에 존재하는 quercetin, myricetin, kaempferol, luteolin, vitexin 등의 플라보노이드 계열 페놀성화합물이 관여함을 시사하였다. 또 이들 화합물 이외의 항산화활성을 나타내는 화합물의 동정이 필요하다고 사료되었다.
The correlation between DPPH radical scavenging activity and total phenolic compound content (Wang et al., J Agric Food Chem, 2003) was evaluated. The results showed that DPPH radical scavenging activity Was found to be the highest in the EtOAc layer with relatively high content of phenolic compounds, indicating that the antioxidative activity of mustard extracts was affected by flavonoid phenolic compounds such as quercetin, myricetin, kaempferol, luteolin, and vitexin . In addition, it is necessary to identify the compounds exhibiting antioxidative activities other than these compounds.
실시예 4: ABTS 라디칼소거능 측정Example 4: Measurement of ABTS radical scavenging ability
마디풀 80% 에탄올 추출물의 2,2'-azinobis-3-ethylbenzothiazoline- 6-sulfonic acid (ABTS) 라디칼소거능을 Re 등(1999)의 방법을 변형하여 다음과 같이 측정하였다. The radical scavenging activity of 2,2'-azinobis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) in the extract of 80%
7 mM ABTS (in water)와 2.45 mM K2O8S2 동량을 혼합한 후 실온, 암소에서 16시간 방치하여 라디칼의 생성을 유도한 후 ABTS+ 라디칼 용액을 희석하여 734 nm에서 흡광도 값이 1.2∼1.3 정도가 되도록 희석하여 사용하였다. 희석한 ABTS+ 라디칼 용액 980 μl 와 생약 추출액 20 μl을 혼합하여 실온에서 15분간 반응시킨 후 734 nm에서 흡광도를 측정하였다. 대조물질로는 1 mM ascorbic acid를 사용하였으며 결과는 시료를 처리하지 않은 군에 대한 %로 표시하였다.After mixing of 7 mM ABTS (in water) and 2.45 mM K 2 O 8 S 2 , the mixture was allowed to stand at room temperature and in a dark place for 16 hours to induce the formation of radicals. The ABTS + radical solution was diluted to a concentration of 1.2 ~ 1.3. ≪ / RTI > 980 μl of the diluted ABTS + radical solution and 20 μl of the herbal extract solution were mixed and reacted at room temperature for 15 minutes and then absorbance was measured at 734 nm. As a control, 1 mM ascorbic acid was used and the results were expressed as% of the untreated sample.
마디풀 80% 에탄올 추출물의 25 mg/mL 농도에서는 61.5±0.8%의 ABTS+ 라디칼 소거능을 나타냄을 알 수 있었으며, 각 분획물중에서도 특히 CHCl3 및 EtOAc 가용부의 25 mg/mL의 농도에서 73.3±1.6 및 78.1±1.8%의 매우 우수한 라디칼소거능을 나타내었으며, 양성 대조구인 (+)-catechin의 활성에 상당하는 효능을 확인하였다. n-BuOH 가용부의 50 mg/mL의 농도에서 67.3±1.8%, 25 mg/ml의 농도에서 40.8±1.9%의 라디칼소거능을 나타내었고, 다음으로 H2O층에서 상대적으로 약한 효능을 나타내었다. [표 4]에서 나타낸 것처럼 총페놀성 함량 상대적으로 높게 나타난 CHCl3, EtOAc, n-BuOH층에 ABTS+ 라디칼 소거 활성물질의 존재가 시사되었으며, 특히 EtOAc층에 대해서 이들 활성물질의 동정이 필요하다고 사료되었다.
The concentration of 25 mg / mL of ethanol extracts of 80% ethanol extract showed 61.5 ± 0.8% of ABTS + radical scavenging ability. Among the fractions, especially at the concentration of 25 mg / mL of CHCl 3 and EtOAc soluble fraction, 73.3 ± 1.6 and 78.1 ± 1.8% and showed the efficacy equivalent to the positive control (+) - catechin activity. n- BuOH soluble fraction at a concentration of 50 mg / mL and a concentration of 40.8 ± 1.9% at a concentration of 25 mg / ml, and then showed a relatively weak effect in the H 2 O layer. As shown in Table 4, the presence of ABTS + radical scavenging activity was shown in the CHCl 3 , EtOAc, and n- BuOH layers, where the total phenolic content was relatively high. Especially, identification of these active substances was required for the EtOAc layer .
실시예 5: Pancreatic lipase 저해활성Example 5: Pancreatic lipase inhibitory activity
Pancreatic lipase 저해활성 측정은 Kim 등(FEMS Microbiol Lett,2007)이 행한 방법을 변형하여 실시하였다. 즉 enzyme buffer(10 mM MOPS, 1 mM EDTA, pH 6.8)에 돼지의 pancreatic lipase를 0.5 g/200 mL의 농도로 4℃를 유지하면서 용해한 후 4000 rpm으로 원심 분리를 하여 상층액을 사용하여 169 uL Tris buffer(100 mM Tris-HCl, 5 mM CaCl2, pH 7.0) 와 6 uL enzyme buffer를 혼합하였다. 샘플은 DMSO로 용해하여 final 농도가 3%가 되도록 한 후 다양한 농도로 희석하여 사용하였다. 기질용액으로 p-nitriphenyl butyrate (p-NPB)을 10 mM이 되게 DMF에 용해한 후 enzyme과 sample을 먼저 37℃에서 15분 동안 shaking incubation 시킨 후 기질을 첨가하여 37℃에서 30분 동안 shaking incubation 시킨 후 405 nm에서 ELISA reader를 이용하여 흡광도를 측정하였다. Pancreatic lipase 저해활성은 시료용액의 첨가군과 무첨가군의 흡광도 감소율로 나타내었다.Pancreatic lipase inhibitory activity was measured by the method of Kim et al. (FEMS Microbiol Lett, 2007). The pancreatic lipase was dissolved in 0.5 g / 200 mL of the enzyme buffer (10 mM MOPS, 1 mM EDTA, pH 6.8) at 4 ° C and centrifuged at 4000 rpm. The supernatant was centrifuged at 169 uL Tris buffer (100 mM Tris-HCl, 5 mM CaCl 2 , pH 7.0) and 6 uL enzyme buffer were mixed. Samples were dissolved in DMSO to a final concentration of 3% and diluted to various concentrations. After dissolving p- nitriphenyl butyrate ( p -NPB) as a substrate solution in DMF for 10 mM, the enzyme and sample were shaking incubated at 37 ° C for 15 min. Substrate was added and shaking incubated at 37 ° C for 30 min. Absorbance was measured at 405 nm using an ELISA reader. Pancreatic lipase inhibitory activity was expressed as the absorbance reduction rate of the sample solution added group and the no added group.
80% 에탄올 추출물의 지방분해효소에 대한 저해능은 50 mg/mL의 농도에서 51.6±1.3%의 강한 저해활성을 나타내었으며, EtOAc층의 경우, 12.5 mg/mL의 농도에서 시판비만 치료제인 orlistat에 상당하는 62.0±1.6% 저해능을 확인하였다. 또한 CHCl3 가용부의 12.5 mg/mL의 농도에서도 60.1±0.9%의 비교적 강한 활성이 확인되었다.
The inhibitory effect of 80% ethanol extract on lipolytic enzyme was 51.6 ± 1.3% at 50 mg / mL and in the case of EtOAc layer at 12.5 mg / mL, orlistat And 62.0 ± 1.6%, respectively. Also, a relatively strong activity of 60.1 ± 0.9% was confirmed at the concentration of 12.5 mg / mL of the CHCl 3 soluble portion.
실험예 1: 마디풀 추출물을 활용한 데리야끼소스의 제조Experimental Example 1: Preparation of teriyaki sauce using Marigold extract
재료준비Material preparation
닭뼈는 경기도 구리시 도매시장에서 국내산을 구입하였고, 청주(백화수복), 간장(샘표 501S), 설탕(큐원 정백당)은 이마트에서 구입하였으며, 대파, 양파, 생강은 이마트에서 국내산을 구입하였고, 프락토올리고당(백설), 자일리톨(로케트사, 프랑스산, 자일리톨 100%), 에리스리톨(Mitsubishi, Japan, 100%), 아가베시럽(Nectarel, Mexico, 유기농 아가베시럽 100%), 스테비오시드(가루나라, 말레이시아, 효소처리 스테비아 100%)는 인터넷으로 구입하였다.
Chicken bones were purchased from Guri city wholesale market. Cheongju (white paprika restoration), soy sauce (Samsepyo 501S) and sugar (Kyungwon white pearl) were purchased from E-Mart. Domae, onion and ginger purchased domestic products from E-Mart, (100%), Erythritol (Mitsubishi, Japan, 100%), Agave syrup (Nectarel, Mexico, 100% organic agave syrup), Stevioside seeds (Garunara, Malaysia, Enzyme treated stevia 100%) was purchased on the Internet.
마디풀 추출물의 함량을 달리한 데리야끼소스의 제조Preparation of Teriyaki Sauce with Different Contents of Marigold Extract
데리야끼소스는 닭뼈 1,000 g을 찬물에 담구어 핏기를 제거하고 240℃의 오븐에서 30분, 양파와 대파는 180℃의 오븐에서 20분간 색깔이 나게 1차로 구웠다. 소스 포트에 각각의 구운 뼈와 양파, 대파를 넣고 1,200 mL의 간장과 600 mL의 청주, 3,000 mL의 물, 850 g의 설탕을 넣어 처음에는 강한 불로 끓이다가, 끓기 시작하면 약한 불로 3시간(180분) 동안 졸인 후 불을 끄고 소창에 곱게 걸러낸 다음, 얼음물에 식혀 기름기를 제거하고 시료로 사용하였다(표 5, Kim HY 등 2011). Teriyaki sauce was soaked in 1,000 g of chicken bone in cold water to remove the puddle and cooked for 30 minutes in an oven at 240 ° C, and onion and loaf in a 180 ° oven for 20 minutes. Put the baked bones, onions and green onions in the sauce pot, add 1,200 mL of soy sauce, 600 mL of sake, 3,000 mL of water, and 850 g of sugar, boil it first with strong fire. Min), the fire was turned off, and the mixture was sifted through a window. Then, the mixture was cooled in ice water to remove grease and used as a sample (Table 5, Kim HY et al. 2011).
보통 감미료의 종류에 따라 감미도에 차이가 나고 사람이 먹기에 맛에서 차이가 나지만, 데리야끼소스는 간장의 맛과 향이 강하여 예비실험인 관능검사 결과 맛과 향에 크게 영향을 주지 못하는 것으로 나타나, 본 실험예에서는 설탕, 아가베시럽, 스테비오시드의 비율을 고정하고 마디풀 추출물의 함량을 조절하여 각각의 소스를 제조하였다.
Although the sweetness varies depending on the kind of sweetener and the taste differs from that of a person, the teriyaki sauce has a strong taste and flavor of soy sauce, In the example, the ratio of sugar, agave syrup, and stevioside was fixed, and the content of coriander extract was adjusted to prepare each source.
실험예에 사용된 배합비율은 하기와 같다.The mixing ratios used in the experimental examples are as follows.
실험예 2: 마디풀 추출물의 함량을 달리한 데리야끼소스의 수분 및 점도Experimental Example 2: Moisture and Viscosity of Teriyaki Sauce with Different Contents of Marigold Extract
수분 함량은 할로겐방식 수분분석기(Moisture Analyzer, MB-45, Ohaus. witzland)를 이용하여 120℃, A60의 측정조건에서 3회 측정하여 평균을 구하였다.Moisture content was measured three times under the measurement conditions of 120 ° C and A60 using a Moisture Analyzer (MB-45, Ohaus, Witland).
점도는 viscometer(DV-Ⅱ+. Brookfield. USA)로 No.3 spindle을 이용하여 60 rpm에서 3회 반복 측정하여 평균을 구하였다(소스 온도: 60±2℃).
The viscosity was measured three times at 60 rpm using a No. 3 spindle with a viscometer (DV-II +, Brookfield, USA) (source temperature: 60 ± 2 ° C).
데리야끼소스에 마디풀추출물(Brix 21)의 함량을 달리 첨가하여 수분과 점도를 측정한 결과는 [표 6]과 같았다. 대조군의 수분 측정결과 22.31%로 나타났고, 마디풀추출물(Brix 21) 100g 첨가한 PA-85는 22.18%, 마디풀추출물(Brix 21) 150g 첨가한 PA-12는 21.42%, 마디풀추출물(Brix 21) 150g 첨가한 PA-55는 20.84%로 나타났다. Table 6 shows the results of measuring the water content and viscosity by adding different amounts of Bombyx mori extract (Brix 21) to teriyaki sauce. The moisture content of the control group was 22.31%. The PA-85 and Brix 21 supplemented with 100g of the extract of Brix 21 were 22.18% and 21.42%, respectively. The PA-55 added was 20.84%.
점도측정 결과는 PA-55(27.58) > PA-12(27.34) > PA-85(26.41)> Con (25.61) 순으로 차이를 보였으며, 수분 함량이 가장 작았던 PA-55의 점도가 가장 높았다.
The viscosity of PA-55 (27.58)> PA-12 (27.34)> PA-85 (26.41)> Con (25.61) showed the highest viscosity and PA-55 having the lowest water content showed the highest viscosity .
실험예 3: 마디풀 추출물의 함량을 달리한 데리야끼소스의 관능검사Experimental Example 3: Sensory evaluation of teriyaki sauce containing different amounts of Marigold extract
데리야끼소스의 관능검사는 훈련을 받은 대구한의대학교 대학원생 11명, 삼성푸드 연구원 6명, 영남대학교 식품가공학과 학생 30명 (평균 나이: 34세, 남22명, 여25명)이 오후 3시에 칸막이가 있는 개인용 검사대에서 실시하였다. 난수표에 의한 세 자리 숫자로 표시된 시료는 흰색의 사기 컵에 담아(30 mL) 제공하였고, 한 개의 시료를 평가한 후 반드시 물로 입안을 헹군 후 다른 시료를 평가하게 하였다. 마디풀 추출물의 함량을 달리한 데리야끼소스의 기호도 검사의 문항은 시료의 외관, 냄새, 맛, 점도, 종합적인 기호도를(매우 좋다=7, 좋다=6, 약간 좋다=5, 보통이다=4, 약간 싫다=3, 싫다=2, 매우 싫다=1), 정량적 묘사분석의 문항은 갈색의 정도, 윤기, 간장향, 단맛, 짠맛, 감칠맛, 점도, 뒷맛의 여운을 7점이 가장 강하고, 1점이 가장 약한 정도로 하여 7점 척도로 평가하였다.The sensory test of teriyaki sauce was conducted at 11:00 pm at Daegu Han University, 6 at Samsung Food Research Institute, 30 students at Yeungnam University (average age: 34 years, 22 males and 25 females) Were performed on a personalized examination table with dividers. The three-digit numbered sample by the random number table was placed in a white scraper cup (30 mL), one sample was evaluated, and the mouth was rinsed with water and then another sample was evaluated. The items of the acceptance test of teriyaki sauce with different contents of Echinochloa crus-galli extracts showed the appearance, odor, taste, viscosity and general preference of the sample (very good = 7, good = 6, slightly good = 5, The results of the quantitative descriptive analysis were as follows: the degree of brownness, gloss, soybean flavor, sweetness, salty taste, richness, viscosity and aftertaste were the strongest in seven points, and one point in the weakest The results were as follows.
마디풀추출물(Brix 21)의 함량을 달리한 데리야끼소스의 정량적 묘사 분석과 기호도 검사를 실시한 결과는 [표 7],[표 8]과 같다. 정량적 묘사 분석 결과 갈색의 정도는 마디풀추출물(Brix 21)의 함량이 가장 높은 PA-55의 데리야끼소스가 가장 강하였으나, 관능검사로서의 그 차이는 크지 않았고, 소스의 윤기 역시 시료들 간에 유의적인 차이를 보이지는 않았다. 간장 향은 마디풀추출물(Brix 21)의 첨가가 적을수록 강하게 나타났으며, 마디풀추출물(Brix 21)의 함량이 가장 높은 것(PA-55)의 경우, 마디풀 특유의 씁쓰름한 맛이 잔존하여 이취로까지 느끼는 경향이 있었다. 단맛의 정도 역시 마디풀 추출물의 함량이 증가할수록 이미로 느끼는 경향이 나타났다. The results of quantitative analysis and preference test of teriyaki sauce with different contents of Brix 21 are shown in [Table 7] and [Table 8]. As a result of quantitative description analysis, the degree of brownness was the strongest in PA-55 teriyaki sauce, which had the highest content of Brix 21, but the difference in sensory evaluation was not significant, and the source luster also showed a significant difference between the samples I did not see it. In case of Brix 21, the highest concentration of Brix 21 (PAI-55) was found in soy safflower, while that of Brix 21 was the highest. Of the population. The degree of sweetness also tended to be higher as the content of Phellinus linteus extract increased.
전체적으로 마디풀 추출물의 함량이 증가할 수록 전체적인 맛의 조화가 흐트러지고, 소스로서의 역할을 기대하기 어렵다는 결론을 내리게 되었다. 하지만 뒷맛의 여운은 마디풀 추출물의 함량이 가장 높은 PA-55가 가장 높게 나타났는데, 다양한 맛을 가짐에도 불구하고 마디풀의 함량이 증가할 경우, 마디풀의 씁쓸한 뒷맛이 잔존함을 알 수 있었다. As a whole, it was concluded that the more harmonized flavor of whole bean sprout extract is, the more difficult it is to expect its role as a sauce. However, PA-55, which had the highest content of Phellinus linteus extract, was the highest in aftertaste, and the bitter aftertaste of Phellinus linteus remained when the content of pancreatic acid was increased despite having various flavors.
따라서 마디풀추출물(Brix 21)의 함량에 따른 데리야끼소스의 관능검사 결과 마디풀 추출물의 함량이 가장 적절한 첨가 배합비율은 마디풀추출물(Brix 21) 100g을 첨가한 데리야끼소스가 가장 맛이 조화로우며, 잔존하는 뒷맛과 간장 향, 간장 맛이 적당하고, 소스의 외관, 냄새, 맛, 텍스처, 전반적인 기호도에서도 가장 선호되는 것으로 나타났다(표 9, 도 1). Therefore, the sensory evaluation of Teriyaki sauce according to the content of Baxter extract (Brix 21) showed that the most appropriate amount of Baxilla extract was the best flavor of Teriyaki sauce added with 100g of Baxter extract (Brix 21) The aftertaste, soy sauce flavor and soy sauce flavor were suitable, and the appearance, smell, taste, texture and general taste of the sauce were the most preferred (Table 9, Fig. 1).
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150072742A KR20150064724A (en) | 2015-05-26 | 2015-05-26 | A Food composition for Teriyaki sauce comprising knotgrass extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150072742A KR20150064724A (en) | 2015-05-26 | 2015-05-26 | A Food composition for Teriyaki sauce comprising knotgrass extract |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120153545A Division KR20140083604A (en) | 2012-12-26 | 2012-12-26 | Composition for prevention and treatment of obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20150064724A true KR20150064724A (en) | 2015-06-11 |
Family
ID=53503185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150072742A KR20150064724A (en) | 2015-05-26 | 2015-05-26 | A Food composition for Teriyaki sauce comprising knotgrass extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20150064724A (en) |
-
2015
- 2015-05-26 KR KR1020150072742A patent/KR20150064724A/en active IP Right Grant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chamorro et al. | Valorization of kiwi agricultural waste and industry by-products by recovering bioactive compounds and applications as food additives: A circular economy model | |
Durak et al. | Coffee with cinnamon–Impact of phytochemicals interactions on antioxidant and anti-inflammatory in vitro activity | |
Liu et al. | Dietary bioactives and essential oils of lemon and lime fruits | |
Satpathy et al. | Preliminary evaluation of nutraceutical and therapeutic potential of raw Spondias pinnata K., an exotic fruit of India | |
KR101003186B1 (en) | preparation method of kimchi using Ixeris dentata, and kimchi produced thereof | |
KR101256728B1 (en) | Powder sauce and process thereof | |
KR101231962B1 (en) | Dressing and process thereof | |
Dimov et al. | Improvement of antioxidant potential of wheat flours and breads by addition of medicinal plants | |
Seal et al. | Nutraceutical and antioxidant properties of Cucumis hardwickii Royle: A potent wild edible fruit collected from Uttarakhand, India | |
Patel | Emerging bioresources with nutraceutical and pharmaceutical prospects | |
Abelti et al. | Review on edible water lilies and lotus: Future food, nutrition and their health benefits | |
KR20120079942A (en) | Hot sauce and process thereof | |
KR101256739B1 (en) | Mixed sauce and process thereof | |
Dangal et al. | A comprehensive review on study of physical, nutritional, and phytochemical characteristics as well as therapeutic activities of Choerospondias axillaris (lapsi) | |
Zayapor et al. | The antioxidant analysis and α-glucosidase inhibition activities of spices and herbs (22 species) in Asian traditional beverages | |
Jeong et al. | Antioxidant and anticancer properties of methanolic extracts from different parts of white, yellow, and red onion | |
KR101399992B1 (en) | Natural seasoning comprising Allium microdictyon and Allium thunbergii | |
KR20140083604A (en) | Composition for prevention and treatment of obesity | |
KR101137891B1 (en) | Sauce composition for chicken boiled containing Kalopanax Pictus | |
Lal et al. | Traditional, medicinal and nutraceutical values of minor fruit: Longan | |
KR101327645B1 (en) | Composition for antioxidative defenses system and muscle fatigue recovery comprising Angelica keiskei extract and Eisenia bicyclis extract as active ingredients | |
Atanassova et al. | Studies on nutritional facts of spring herbs collected from Bulgarian market | |
Das et al. | A Comparative study of the antioxidative propertiesof the different seed spices available in India | |
KR20150064724A (en) | A Food composition for Teriyaki sauce comprising knotgrass extract | |
Chen et al. | Functional Evaluation of Loquat (Eriobotrya japonica Lindl.) Flower Water Extracts and Its Potential Use in Tea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |